insights_auto
Why is AGIO down 3,23%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
31,76 USD
arrow_downward
-3,23%(-1,06) 1D
31,76 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 12-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
32,56 USD
High
32,76 USD
Low
31,56 USD
Mkt. cap
1,90 млд
Avg. vol.
1,29 млн
Volume
497,04 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
32,56 USD
High
32,76 USD
Low
31,56 USD
Mkt. cap
1,90 млд
Avg. vol.
1,29 млн
Volume
497,04 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
Eurasia Business News
·
43 мүнөт мурун
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
Investing.com
·
2 саат мурун
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.36%
BeInCrypto
·
3 саат мурун
S&P 500 Recovered $1 Trillion in 90 Minutes Despite Wider Market Crash
Traders Union
·
2 саат мурун
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc